172 related articles for article (PubMed ID: 11169019)
1. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients.
Massy ZA; Ceballos I; Chadefaux-Vekemens B; Nguyen-Khoa T; Descamps-Latscha B; Drüeke TB; Jungers P
Kidney Int Suppl; 2001 Feb; 78():S243-5. PubMed ID: 11169019
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Stühlinger MC; Stanger O
Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.
Tawakol A; Omland T; Gerhard M; Wu JT; Creager MA
Circulation; 1997 Mar; 95(5):1119-21. PubMed ID: 9054838
[TBL] [Abstract][Full Text] [Related]
5. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
Sydow K; Böger RH
Z Kardiol; 2001 Jan; 90(1):1-11. PubMed ID: 11220081
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine and vascular dysfunction.
Lentz SR
Life Sci; 1997; 61(13):1205-15. PubMed ID: 9324062
[TBL] [Abstract][Full Text] [Related]
7. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
Lentz SR; Malinow MR; Piegors DJ; Bhopatkar-Teredesai M; Faraci FM; Heistad DD
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
9. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Sydow K; Schwedhelm E; Arakawa N; Bode-Böger SM; Tsikas D; Hornig B; Frölich JC; Böger RH
Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
[TBL] [Abstract][Full Text] [Related]
10. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
Stanger O; Weger M; Renner W; Konetschny R
Clin Chem Lab Med; 2001 Aug; 39(8):725-33. PubMed ID: 11592442
[TBL] [Abstract][Full Text] [Related]
11. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans.
Kanani PM; Sinkey CA; Browning RL; Allaman M; Knapp HR; Haynes WG
Circulation; 1999 Sep; 100(11):1161-8. PubMed ID: 10484535
[TBL] [Abstract][Full Text] [Related]
12. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
Böger RH; Lentz SR; Bode-Böger SM; Knapp HR; Haynes WG
Clin Sci (Lond); 2001 Feb; 100(2):161-7. PubMed ID: 11171285
[TBL] [Abstract][Full Text] [Related]
13. Homocyst(e)ine, atherosclerosis, and thrombosis.
Alpert MA
South Med J; 1999 Sep; 92(9):858-65. PubMed ID: 10498159
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
Stühlinger MC; Oka RK; Graf EE; Schmölzer I; Upson BM; Kapoor O; Szuba A; Malinow MR; Wascher TC; Pachinger O; Cooke JP
Circulation; 2003 Aug; 108(8):933-8. PubMed ID: 12912818
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1997 Dec; 20(12):1880-6. PubMed ID: 9405911
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine as a novel risk factor for atherosclerosis.
Guthikonda S; Haynes WG
Curr Opin Cardiol; 1999 Jul; 14(4):283-91. PubMed ID: 10448607
[TBL] [Abstract][Full Text] [Related]
17. Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure.
Takamitsu Y; Nakanishi T
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S95-9. PubMed ID: 11576931
[TBL] [Abstract][Full Text] [Related]
18. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
Lentz SR; Sobey CG; Piegors DJ; Bhopatkar MY; Faraci FM; Malinow MR; Heistad DD
J Clin Invest; 1996 Jul; 98(1):24-9. PubMed ID: 8690798
[TBL] [Abstract][Full Text] [Related]
19. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia.
Eberhardt RT; Forgione MA; Cap A; Leopold JA; Rudd MA; Trolliet M; Heydrick S; Stark R; Klings ES; Moldovan NI; Yaghoubi M; Goldschmidt-Clermont PJ; Farber HW; Cohen R; Loscalzo J
J Clin Invest; 2000 Aug; 106(4):483-91. PubMed ID: 10953023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
